ArticlePharmaceuticals (Basel, Switzerland)2026
Psychiatric Adverse Events and Administration Challenges Associated with GLP-1 Receptor Agonists for Weight Loss: A Real-World Analysis.
Ali Hindi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.